241 related articles for article (PubMed ID: 12716409)
1. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
[TBL] [Abstract][Full Text] [Related]
3. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry.
Walker CD; Tilders FJ; Burlet A
J Neuroendocrinol; 2001 Jan; 13(1):74-85. PubMed ID: 11123517
[TBL] [Abstract][Full Text] [Related]
4. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
5. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
Dakine N; Oliver C; Grino M
J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
[TBL] [Abstract][Full Text] [Related]
6. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response.
Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616
[TBL] [Abstract][Full Text] [Related]
7. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats.
Al-Barazanji KA; Wilson S; Baker J; Jessop DS; Harbuz MS
J Neuroendocrinol; 2001 May; 13(5):421-4. PubMed ID: 11328451
[TBL] [Abstract][Full Text] [Related]
8. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
Walker CD; Tankosic P; Tilders FJ; Burlet A
J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
[TBL] [Abstract][Full Text] [Related]
9. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus.
Paulmyer-Lacroix O; Anglade G; Grino M
J Mol Endocrinol; 1994 Dec; 13(3):313-20. PubMed ID: 7893349
[TBL] [Abstract][Full Text] [Related]
10. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
[TBL] [Abstract][Full Text] [Related]
11. Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons.
Herman JP; Schäfer KH; Sladek CD; Day R; Young EA; Akil H; Watson SJ
Brain Res; 1989 Nov; 501(2):235-46. PubMed ID: 2819439
[TBL] [Abstract][Full Text] [Related]
12. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
Ma XM; Levy A; Lightman SL
Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
[TBL] [Abstract][Full Text] [Related]
13. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
Schwartz MW; Strack AM; Dallman MF
Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
[TBL] [Abstract][Full Text] [Related]
14. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
Viau V; Soriano L; Dallman MF
J Neuroendocrinol; 2001 May; 13(5):442-52. PubMed ID: 11328455
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.
Arima H; Aguilera G
J Neuroendocrinol; 2000 Sep; 12(9):833-42. PubMed ID: 10971808
[TBL] [Abstract][Full Text] [Related]
16. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
Ogilvie KM; Rivier C
Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
[TBL] [Abstract][Full Text] [Related]
18. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
19. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
Dakine N; Oliver C; Grino M
Life Sci; 2000 Oct; 67(23):2827-44. PubMed ID: 11105998
[TBL] [Abstract][Full Text] [Related]
20. Differential actions of acute and chronic citalopram on the rodent hypothalamic-pituitary-adrenal axis response to acute restraint stress.
Hesketh S; Jessop DS; Hogg S; Harbuz MS
J Endocrinol; 2005 Jun; 185(3):373-82. PubMed ID: 15930163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
